BRIACELL THERAPEUTICS CORP. Payments for Repurchase of Equity
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- BRIACELL THERAPEUTICS CORP. payments for repurchase of equity for the quarter ending 2023-07-31 was $0.00, a 100.00% decline year-over-year.
- BRIACELL THERAPEUTICS CORP. payments for repurchase of equity for the quarter ending 2023-04-30 was $0.00, a 100.00% decline year-over-year.
- BRIACELL THERAPEUTICS CORP. payments for repurchase of equity for the quarter ending 2023-01-31 was $0.00.
- BRIACELL THERAPEUTICS CORP. payments for repurchase of equity for the quarter ending 2022-10-31 was $47.29K.
- BRIACELL THERAPEUTICS CORP. payments for repurchase of equity for fiscal 2023 was $47.29K, a 99.54% decline from fiscal 2022.
- BRIACELL THERAPEUTICS CORP. payments for repurchase of equity for fiscal 2022 was $10.17M.
| Period end | Payments for Repurchase of Equity 3 month | Payments for Repurchase of Equity 12 month |
|---|---|---|
| 2023-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-29 | $47.29K 10-K · filed 2024-10-29 |
| 2023-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-06-14 | $149.96K derived: sum of 4 quarters · filed 2024-06-14 |
| 2023-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-03-18 | $162.75K derived: sum of 4 quarters · filed 2024-03-18 |
| 2022-10-31 | $47.29K 10-Q · filed 2023-12-14 | |
| 2022-07-31 | $102.67K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-25 | $10.17M 10-K · filed 2023-10-25 |
| 2022-04-30 | $12.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |